-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$200.0080.36% Upside
Recent Analyst Forecasts and Stock Ratings
Jazz Pharmaceuticals plc Frequently Asked Questions
-
What analysts cover Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc has been rated by research analysts at Stifel Nicolaus, Goldman Sachs, RBC Capital, Piper Sandler, UBS, Needham in the past 90 days.